Table 5 Sleep disruption related parameters in the YAC cohort. Data are mean ± SD or number (%)
From: Impairment in sleep health in young adults with chronic pain: a modifiable risk factor
Variable | Nocturnal symptoms present (n = 39) | No Nocturnal symptoms (n = 16) | P value |
|---|---|---|---|
Age | 20.59 ± 2.6 | 19.56 ± 1.8 | 0.149 |
Gender M:F | 7:31 (17.9%:79.5%) | 6:9 (37.5%:56.2%) | 0.212 |
PSEQa score (0–60) | 24.90 ± 13.2 | 34.43 ± 16.9 | 0.041 |
Low Pain self efficacy (PSEQ < 30/60) | 19/34 (57.6%) | 3/14 (21.4%) | 0.023 |
PHQ-9b (0–27) | 14.09 ± 6.7 | 13.71 ± 9.1 | 0.053 |
 Total depressed (> 5/27) | 31/34 (91.2%) | 13/14 (92.9%) | 0.915 |
 Mild (5–9) | 9/34 (27.3%) | 6/14 (42.9%) | 0.442 |
 Moderate (10–19) | 14/34 (42.4%) | 3/14 (21.4%) | |
 Severe (20–27) | 8/34 (24.2%) | 4/14 (28.6%) | |
PCSc | |||
 Low risk | 7/32 (21.9%) | 7/14 (50%) | 0.139 |
 Moderate risk | 11/32 (34.4%) | 4/14 (28.6%) | |
 Severe risk | 14/32 (43.8%) | 3/14 (21.4%) | |
Transition-Q score | 21.75 ± 6.1 | 21.86 ± 4.1 | 0.953 |